Stem cell therapy for multiple sclerosis

Evaluation of advantages and toxicity of stem cell therapy to alleviate disease activity and severity of patients with multiple sclerosis

Stem cells can also treat diseases related to brain diseases and brain degeneration. Stem cell therapy is being studied to properly treat diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. Stem cell therapy for autism is known to provide neuroprotection and can also help restore behavior. Stem cell therapy for heart disease contributes to cardiomyocyte production, secretion of growth factors, promotion of new healthy blood vessel growth, and other types of aid. Stem cell therapy uses autologous bone marrow stem cells and "adipose derived" stem cells

One of the areas that has gained wide attention now is stem cell research. Medical researchers and practitioners currently believe that stem cell therapy is the key to treating diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and certain cancers. Stem cells are unique in that they are capable of proliferating in vivo and differentiating into different cell types. They can develop into various body tissues or organs and because they can replace damaged cells by injury or disease, they have a very great healing potential.

The injection of healthy stem cells into patients called "stem cell therapy" has great expectations for the treatment of hereditary and non-hereditary diseases such as type 1 mucopolysaccharidoses, Parkinson's disease, multiple sclerosis, multiple immunodeficiency diseases I am pushing. Aplastic disease disease stem cells for anemia cell therapy can be taken from a patient (self), or from other "healthy" individuals (allogeneic). Using allogeneic stem cells with transplanted donor T cells will eliminate the potentially fatal risk of patient cells, a process known as "graft-versus-host disease". Therefore, it is preferable to use autologous stem cells from at least immunological viewpoint. However, one obvious disadvantage is essentially called "self", which includes disease mutations. This review summarizes the controversy over the transduction of stem cells with AAV vectors, hoping to set up stem cells.